about
Pathogenesis of coronary artery disease: focus on genetic risk factors and identification of genetic variantsHighlights of the year in JACC 2012Pharmacogenomics and Global Precision Medicine in the Context of Adverse Drug Reactions: Top 10 Opportunities and Challenges for the Next DecadeFuture translational applications from the contemporary genomics era: a scientific statement from the American Heart AssociationUse of genetic data to guide therapy in arterial disease.Systems biology applied to heart failure with normal ejection fractionIs There a Role for Genomics in the Management of Hypertension?Warfarin Therapy: Survey of Patients' Knowledge of their Drug Regimen.Drug-induced arrhythmia: pharmacogenomic prescribing?Clinical pharmacogenomics: opportunities and challenges at point of careNon-response to (statin) therapy: the importance of distinguishing non-responders from non-adherers in pharmacogenetic studies.The genetic basis for survivorship in coronary artery disease.Multiple sclerosis: individualized disease susceptibility and therapy response.Gene Expression Signatures and the Spectrum of Coronary Artery Disease.Pharmacokinetic Variability of Drugs Used for Prophylactic Treatment of Migraine.Review of the Reported Measures of Clinical Validity and Clinical Utility as Arguments for the Implementation of Pharmacogenetic Testing: A Case Study of Statin-Induced Muscle Toxicity.Delivering pharmacogenetic testing in a primary care setting.Should we revise our approach to 'optimal medical therapy'? The case of chronic heart failure.The development and validation of a decision-analytic model representing the full disease course of acute myeloid leukemia.Pharmacogenetics in cardiovascular disease: the challenge of moving from promise to realization: concepts discussed at the Canadian Network and Centre for Trials Internationally Network Conference (CANNeCTIN), June 2009.
P2860
Q24273409-6B57E328-2A38-498B-BEF1-2DE8477FB510Q26865608-E11CAD1C-1BA9-41BA-BC7E-21880AAA0E45Q28392069-4B4EBCE3-8376-4B14-BAD7-DC783EB139DAQ30359686-BB3AEF98-7FDC-4B2D-8C95-69E2D80E5936Q30978916-25239DFB-3C8D-41ED-8490-45A3E77BD9C2Q33733448-CB2B0153-1A0B-4D4F-82C4-7DA62C330722Q33838442-E9972606-6C03-4CB0-80A3-0019E12C68EEQ35564521-3219C6E6-77D3-4277-855C-AFD83A93D14BQ36512441-6B1180CA-DAE4-475C-8A8D-2E78676CACAFQ36622897-39B0BDAC-C53C-420A-BA3A-0796DF9B62EAQ36688483-05579281-01B1-4CF3-8DBA-6063B5318839Q37201894-1F537820-7741-496B-A24C-FC89896CA08FQ38079620-796924CA-F940-4A92-95D7-363602C4FE25Q38531858-70B47566-65CD-444C-BB2C-D015579DCC99Q39239760-58734E05-4ABD-462C-AE2F-A75F55667564Q41526681-1CF871D3-2CFE-4D0A-98E8-9C8060B6670AQ41981549-A69B1243-8D39-4E4B-9156-0438EF40BBE5Q43722663-6A960BB2-8693-4D61-9794-819DABA7F36DQ45095746-0576EC2C-FA49-40B7-B2D1-32029761E33DQ45337198-1DDCBFE6-9C1A-4C76-95E2-DF26EB1D30A3
P2860
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Clinical application of cardiovascular pharmacogenetics
@ast
Clinical application of cardiovascular pharmacogenetics
@en
Clinical application of cardiovascular pharmacogenetics
@nl
type
label
Clinical application of cardiovascular pharmacogenetics
@ast
Clinical application of cardiovascular pharmacogenetics
@en
Clinical application of cardiovascular pharmacogenetics
@nl
prefLabel
Clinical application of cardiovascular pharmacogenetics
@ast
Clinical application of cardiovascular pharmacogenetics
@en
Clinical application of cardiovascular pharmacogenetics
@nl
P3181
P1476
Clinical application of cardiovascular pharmacogenetics
@en
P2093
Geoffrey S Ginsburg
P3181
P356
10.1016/J.JACC.2012.01.067
P407
P50
P577
2012-07-01T00:00:00Z